Abstract. The hepatoprotective effects of ACTIValoe ® N-931 complex, a mixture of Aloe vera and Silybum marianum, against acute and chronic carbon tetrachloride (CCl 4 )-induced liver injuries were investigated. Acute hepatotoxicity was induced by intraperitoneal injection of CCl 4 (50 μl / kg), and ACTIValoe ® N-931 complex at 85, 170, and 340 mg / kg was administered orally 48, 24, and 2 h before and 6 h after injection of CCl 4 . Hepatotoxicity was assessed 24 h after CCl 4 treatment. Liver fibrosis was induced by intraperitoneal injection of CCl 4 for 8 weeks (0.5 ml / kg, twice per week), and mice were treated with ACTIValoe ® N-931 complex at 85, 170, or 340 mg / kg once a day (p.o.). In both acute hepatotoxicity and liver fibrosis, serum aminotransferase levels and lipid peroxidation were increased and the hepatic glutathione content was decreased. These changes were prevented by ACTIValoe